Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases-Current Clinical Approach

Area of Science:

• Gastroenterology
• Nutritional Science
• Pharmacology

Background:

• Butyrate is crucial for intestinal health and function.
• Sodium butyrate exhibits anti-inflammatory and immunomodulatory properties beneficial for intestinal diseases.
• Encapsulation technologies aim to enhance sodium butyrate's effectiveness and patient compliance.

Purpose of the Study:

• To review the utility, efficacy, and safety of sodium butyrate preparations.
• To evaluate microencapsulated forms of sodium butyrate in managing major intestinal diseases.
• To assess the impact of formulation on sodium butyrate's therapeutic outcomes.

Main Methods:

• Comprehensive literature review.
• Analysis of sodium butyrate preparations, including microencapsulated forms.
• Discussion of clinical data for inflammatory bowel diseases, irritable bowel syndrome, and diverticular disease.

Main Results:

• Advanced microencapsulated sodium butyrate shows potential as an add-on therapy for intestinal conditions.
• Efficacy is influenced by delivery technology, release profile, and dosage due to rapid absorption.
• Specific microencapsulated formulations, like MSB® technology, are valuable therapeutic options.

Conclusions:

• Microencapsulated sodium butyrate preparations are promising for managing intestinal diseases.
• Clinical outcomes are formulation-dependent, necessitating assessment of specific preparations.
• Formulation significantly impacts the efficacy of sodium butyrate treatments.